#AACR2023 Brenus Pharma unveils groundbreaking preclinical results For STC-10101, a promising new drug candidate targeting colorectal cancer & solid tumors
French Blood Establishment (EFS) & Brenus Pharma partner for the GMP production of STC-1010, an innovative therapy against colorectal cancer
Brenus Pharma announces its strategic committee supporting & ensuring its value-creating strategic plan
